Going Beyond Results of the PEMBRO-RT Trial-Reply
JAMA Oncol
.
2020 Jan 1;6(1):162.
doi: 10.1001/jamaoncol.2019.5034.
Authors
Willemijn S M E Theelen
1
,
Paul Baas
1
Affiliation
1
Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
PMID:
31750858
DOI:
10.1001/jamaoncol.2019.5034
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized*
Antineoplastic Combined Chemotherapy Protocols*
Humans
Substances
Antibodies, Monoclonal, Humanized